Marshall Fordyce - Sep 1, 2022 Form 4/A - Amendment Insider Report for Vera Therapeutics, Inc. (VERA)

Role
President and CEO, Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
9/13/2022, 04:09 PM
Date Of Original Report
Sep 6, 2022
Previous filing
Aug 23, 2022
Next filing
Sep 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERA Stock Option (right to buy) 1.07M Sep 1, 2022 Class A Common Stock 17.1K $2.90 Direct F1, F2
holding VERA Stock Option (right to buy) 1.05M Sep 1, 2022 Class A Common Stock 17.1K $2.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.
F2 The reporting person's original Form 4 contained a typographical error on the total number of derivative securities beneficially owned following the reported transaction.